Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 11:22 PM
Study NCT ID:
NCT00003693
Status:
COMPLETED
Last Update Posted:
2018-10-25
First Post:
1999-11-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2001-10-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2001-10-30
Completion Date Type:
ACTUAL
First Submit Date:
1999-11-01
First Submit QC Date:
None
Study First Post Date:
2004-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-23
Last Update Post Date:
2018-10-25
Last Update Post Date Type:
ACTUAL